A. J. Kazimi - 16 Aug 2023 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
A.J. Kazimi by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
16 Aug 2023
Net transactions value
+$1,261
Form type
4
Filing time
08 Sep 2023, 17:03:20 UTC
Previous filing
27 Mar 2023
Next filing
03 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $107 +65 +0% $1.64 5,716,218 16 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $110 +65 +0% $1.70 5,716,283 17 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $110 +65 +0% $1.70 5,716,348 18 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $109 +65 +0% $1.68 5,716,413 21 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $112 +65 +0% $1.72 5,716,478 22 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $110 +65 +0% $1.70 5,716,543 23 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $45.63 +27 +0% $1.69 5,716,570 24 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $110 +65 +0% $1.70 5,716,635 25 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $111 +65 +0% $1.71 5,716,700 28 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $117 +70 +0% $1.67 5,716,770 29 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $109 +65 +0% $1.68 5,716,835 30 Aug 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $109 +65 +0% $1.67 5,716,900 31 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023.